ArticleFrontiers in veterinary science2026
PI3K over-expression drives canine mammary tumor progression.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canine mammary tumor (CMT) represents the most frequently diagnosed neoplasm in intact female dogs and exhibits a high malignant rate. The PI3K/AKT pathway critically drives tumor progression, and serves as a target for multiple anti-tumor drugs. In this study, two CMT cell lines (CHMp and CIPm) were employed to assess the impact of lentivirus-mediated PI3K over-expression. Functional assays were performed to evaluate proliferation, migration, and invasion capacities, as well as the expression levels of associated proteins. As a result, PI3K over-expressing cells exhibited a significantly increase in proliferation, migration, and invasion compared to cells in negative control (NC) group. Additionally, western blot analyses revealed that PI3K over-expression evoked concordant alterations in apoptosis-related proteins, including elevated phospho-AKT and Bcl-2 coupled with reduced Bax, implying that PI3K-mediated attenuation of apoptosis facilitated tumor progression. Moreover, results from tumor xenograft mouse model experiments indicated that PI3K over-expression significantly promotes tumor growth
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.